L’APPROCCIO INTEGRATO AI DISTURBI GASTROINTESTINALI: RUOLO DEL FARMACISTA TERRITORIALE COME GATEKEEPER E PRIMO CONSULENTE

1. 1.Eric D Shah et al.. Heartburn Relief Is the Major Unmet Need for Drug Development in Gastroesophageal Reflux Disease: Threshold Value Analysis. Clin Gastroenterol Hepatol. 2025 Feb;23(2):263-271.. 2025
   Articolo scientificoClin Gastroenterol Hepatol. 2025 Feb;23(2):263-271.Leggi il PDF gratuito
2. 2.MacFarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist's perspective.. Integr Pharm Res Pract. 2018 Jun 5;7:41-52. 2018
   Articolo scientificoIntegr Pharm Res Pract. 2018 Jun 5;7:41-52Leggi il PDF gratuito
3. 3.Meyer JC, et al.. Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications.. Cureus. 2022 Nov 26;14(11):e31918. 2022
   Articolo scientificoCureus. 2022 Nov 26;14(11):e31918Leggi il PDF gratuito
4. 4.Grant A et al.. Uptake of community pharmacist prescribing over a three-year period.. Explor Res Clin Soc Pharm. 2023 Jan 7;9:100221. 2023
   Articolo scientificoExplor Res Clin Soc Pharm. 2023 Jan 7;9:100221Leggi il PDF gratuito
5. 5.Sapkota B et al.. A systematic review and meta-analysis on pharmacist-led interventions for the management of peptic ulcer disease.. PLoS One. 2025 Mar 25;20(3):e0320181.. 2025
   Articolo scientificoPLoS One. 2025 Mar 25;20(3):e0320181.Leggi il PDF gratuito
6. 6.Afshan A. Rationale use of proton pump inhibitors: Observational study of hospital based prescriptions and role of clinical pharmacist.. Pak J Pharm Sci. 2018 Jul;31(4):1217-1227.. 2018
   Articolo scientificoPak J Pharm Sci. 2018 Jul;31(4):1217-1227.Cerca su Google Scholar

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).